Latest Ally Bridge Group (NY) LLC Stock Portfolio
$113Million | No. of Holdings #23
Ally Bridge Group (NY) LLC Performance
2026 Q2+4.91%
YTD+12.67%
2025+5.44%
About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings
Ally Bridge Group (NY) LLC is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $113.1 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Ally Bridge Group (NY) LLC are NERV, PMN, . The fund has invested 10.7% of it's portfolio in MINERVA NEUROSCIENCES INC and 7.2% of portfolio in PROMIS NEUROSCIENCES INC. <br><br> The fund managers got completely rid off PRAXIS PRECISION MEDICINES I (PRAX), COMPASS PATHWAYS PLC (CMPS) and TARSUS PHARMACEUTICALS INC (TARS) stocks. They significantly reduced their stock positions in OVID THERAPEUTICS INC (OVID), SOLID BIOSCIENCES INC (SLDB) and UROGEN PHARMA LTD (URGN). Ally Bridge Group (NY) LLC opened new stock positions in FIRST TRACKS BIOTHERAPEUTICS, AXSOME THERAPEUTICS INC (AXSM) and ASSEMBLY BIOSCIENCES INC (ASMB). The fund showed a lot of confidence in some stocks as they added substantially to PROMIS NEUROSCIENCES INC (PMN) and MINERVA NEUROSCIENCES INC (NERV).
Ally Bridge Group (NY) LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$113Million
as of Aug 14, 2026Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ally Bridge Group (NY) LLC made a return of 4.91% in the last quarter. In trailing 12 months, it's portfolio return was 17.93%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| first tracks biotherapeutics | 5,719,850 |
| axsome therapeutics inc | 4,036,990 |
| assembly biosciences inc | 3,847,200 |
| climb bio inc | 3,249,200 |
| kura oncology inc | 3,181,300 |
| avalo therapeutics inc | 2,772,000 |
| palisade bio inc | 2,568,610 |
| ideaya biosciences inc | 2,515,720 |
New stocks bought by Ally Bridge Group (NY) LLC
Additions
| Ticker | % Inc. |
|---|---|
| promis neurosciences inc | 49.76 |
| minerva neurosciences inc | 31.43 |
Additions to existing portfolio by Ally Bridge Group (NY) LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ovid therapeutics inc | -77.84 |
| solid biosciences inc | -66.63 |
| urogen pharma ltd | -65.77 |
| eupraxia pharmaceuticals inc | -61.81 |
| alumis inc | -54.2 |
| edgewise therapeutics inc | -48.26 |
| perspective therapeutics inc | -19.71 |
| inventiva sa | -14.83 |
Ally Bridge Group (NY) LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| inhibikase therapeutics inc | -2,226,000 |
| compass pathways plc | -5,778,850 |
| relmada therapeutics inc | -1,465,250 |
| capricor therapeutics inc | -3,462,530 |
| tarsus pharmaceuticals inc | -5,672,260 |
| praxis precision medicines i | -10,571,100 |
Ally Bridge Group (NY) LLC got rid off the above stocks
Sector Distribution
Ally Bridge Group (NY) LLC has about 81.3% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 81.3 |
| Others | 18.7 |
Market Cap. Distribution
Ally Bridge Group (NY) LLC has about 10% of it's portfolio invested in the large-cap and mega-cap stocks.
- MICRO-CAP
- SMALL-CAP
- UNALLOCATED
- MID-CAP
- LARGE-CAP
- MEGA-CAP
| Category | % |
|---|---|
| MICRO-CAP | 35.3 |
| SMALL-CAP | 28.4 |
| UNALLOCATED | 18.7 |
| MID-CAP | 7.6 |
| LARGE-CAP | 5.2 |
| MEGA-CAP | 4.8 |
Stocks belong to which Index?
About 27.2% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 72.8 |
| RUSSELL 2000 | 27.2 |
Ally Bridge Group (NY) LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC has 23 stocks in it's portfolio. About 44.5% of the portfolio is in top 10 stocks. IVA proved to be the most loss making stock for the portfolio. URGN was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.
$77.60MTotal Value
29.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Whitehawk Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Whitehawk Therapeutics Inc over time | 3.31% | 817,939 | $3.75M 3.31% | 0%unchanged 0 percentunchanged | |
 An2 Therapeutics Inc Ally Bridge Group (NY) LLC's holding in An2 Therapeutics Inc over time | 2.25% | 526,315 | $2.55M 2.25% | 0%unchanged 0 percentunchanged | |
 Assembly Biosciences Inc Ally Bridge Group (NY) LLC's holding in Assembly Biosciences Inc over time | 3.4% | 140,000 | $3.85M 3.4% | Newnew position | |
 Avalo Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Avalo Therapeutics Inc over time | 2.45% | 150,000 | $2.77M 2.45% | Newnew position | |
 Axsome Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Axsome Therapeutics Inc over time | 3.57% | 16,493 | $4.04M 3.57% | Newnew position | |
 Capricor Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Capricor Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Cytomx Therapeutics Inc. Ally Bridge Group (NY) LLC's holding in Cytomx Therapeutics Inc. over time | 2.57% | 775,000 | $2.91M 2.57% | 13.89%decreased 13.89 percentreduced | |
 Climb Bio Inc Climb Bio IncELYM Ally Bridge Group (NY) LLC's holding in Climb Bio Inc over time | 2.87% | 249,172 | $3.25M 2.87% | Newnew position | |
 Edgewise Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Edgewise Therapeutics Inc over time | 2.99% | 83,300 | $3.38M 2.99% | 48.26%decreased 48.26 percentreduced | |
| 0.6% | 390,147 | $682.8K 0.6% | Newnew position | ||
 Ideaya Biosciences Inc Ally Bridge Group (NY) LLC's holding in Ideaya Biosciences Inc over time | 2.22% | 67,500 | $2.52M 2.22% | Newnew position | |
 Inhibikase Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Inhibikase Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 IVA Inventiva SaInventiva SaIVA | 2.12% | 634,800 | $2.40M 2.12% | 14.83%decreased 14.83 percentreduced | |
 Kura Oncology Inc Ally Bridge Group (NY) LLC's holding in Kura Oncology Inc over time | 2.81% | 290,000 | $3.18M 2.81% | Newnew position | |
 Minerva Neurosciences Inc Ally Bridge Group (NY) LLC's holding in Minerva Neurosciences Inc over time | 10.68% | 2,175,800 | $12.08M 10.68% | 31.43%increased 31.43 percentadded | |
 Traws Pharma Inc Traws Pharma IncONTX Ally Bridge Group (NY) LLC's holding in Traws Pharma Inc over time | 0.59% | 786,236 | $663.0K 0.59% | Newnew position | |
 Ovid Therapeutics Inc Ally Bridge Group (NY) LLC's holding in Ovid Therapeutics Inc over time | 1.49% | 624,561 | $1.68M 1.49% | 77.84%decreased 77.84 percentreduced | |
 Palisade Bio Inc Palisade Bio IncPALI Ally Bridge Group (NY) LLC's holding in Palisade Bio Inc over time | 2.27% | 1,229,000 | $2.57M 2.27% | Newnew position | |
 Promis Neurosciences Inc Ally Bridge Group (NY) LLC's holding in Promis Neurosciences Inc over time | 7.22% | 620,319 | $8.16M 7.22% | 49.76%increased 49.76 percentadded | |
